Graft failure after “ex-vivo” T-cell depleted haploidentical transplantation in pediatric patients with high-risk hematological malignancies. A risk factors and outcomes analysis

References

• Rocha V, Locatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant. 2008;41(2):207–214.
   PubMed Web of Science ®Google Scholar
• Martelli MF, Reisner Y. Haploidentical “'megadose' CD34+ cell transplants for patients with acute leukemia”. Leukemia. 2002;16(3):404–405.
   PubMed Web of Science ®Google Scholar
• Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med. 1998;339(17):1186–1193.
   PubMed Web of Science ®Google Scholar
• Reisner Y, Aversa F, Martelli MF. Haploidentical hematopoietic stem cell transplantation: state of art. Bone Marrow Transplant. 2015;50(S2):S1–S53.
   PubMed Web of Science ®Google Scholar
• Martelli MF, Aversa F. Haploidentical transplants using ex vivo T-cell depletion. Semin Hematol. 2016;53(4):252–256.
   PubMed Web of Science ®Google Scholar
• Anasetti C, Amos D, Beatty PG, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med. 1989;320(4):197–204.
   PubMed Web of Science ®Google Scholar
• Kernan NA, Flomenberg N, Dupont B, et al. Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation. 1987;43(6):842–847.
   PubMed Web of Science ®Google Scholar
• Yoshihara S, Maruya E, Taniguchi K, et al. Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT. Bone Marrow Transplant. 2012;47(4):508–515.
   PubMed Web of Science ®Google Scholar
• Bramanti S, Calafiore V, Longhi E, et al. Donor-specific anti-HLA antbodies in haploidentical stem cell transplantation with post-cyclophosphamide: risk of graft failure, poor graft function, and impact on outcomes. BBMT. 2019;25:1395–1406.
   Google Scholar
• Meng L, Zhai S-Z, Wang Y, et al. Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factors. BMT. 2019;54:1287–1294.
   Google Scholar
• Perez-Martinez A, Gonzalez-Vicent M, Valentin J, et al. Early evaluation of immune reconstitution following allogeneic CD3/CD19-depleted grafts from alternative donors in childhood acute leukemia. Bone Marrow Transplant. 2012;47:1419–1427.
   PubMed Web of Science ®Google Scholar
• Diaz MA, Pérez-Martínez A, Herrero B, et al. Prognostic factors and outcomes for pediatric patients receiving an haploidentical relative allogeneic transplant using CD3/CD19-depleted grafts. Bone Marrow Transplant. 2016;51(9):1211–1216.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Vicent M, Perez A, Abad L, et al. Graft manipulation and reduced-intensity conditioning for allogeneic hematopietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients. J Pediat Hematol Oncol. 2010; 32:85–90.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Merli P, Pagliara D, et al. Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion. Blood. 2017;130(5):677–685.
   PubMed Web of Science ®Google Scholar
• Maschan M, Shelikhova L, Ilushina M, et al. TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia . Bone Marrow Transplant. 2016;51(5):668–674.
   PubMed Web of Science ®Google Scholar
• Diaz MA, Zubicaray J, Molina B, et al. Haploidentical stem cell transplantation in children with hematological malignancies using αβ(+) T-cell receptor and CD19(+) cell depleted grafts: high CD56(dim)/CD56(bright) NK cell ratio early following transplantation is associated with lower relapse incidence and better outcome. Front Immunol. 2019;10:2504.
   PubMed Web of Science ®Google Scholar
• Cooley S, Weisdorf DJ, Guethlein LA, et al. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood. 2010;116(14):2411–2419.
   PubMed Web of Science ®Google Scholar
• Ciurea SO, Cao K, Fernandez-Vina M, et al. The European Society for Blood and Marrow Transplantation (EBMT) consensus guidelines for the detection and treatment of donor-specific anti-HLA antibodies (DSA) in haploidentical hematopoietic cell transplantation. Bone Marrow Transplant. 2018;53(5):521–534.
   PubMed Web of Science ®Google Scholar
• Sevilla J, Guillen M, Galvez E, et al. Immunomagnetic T cell depletion: an analysis of variables affecting final cell yield. Clin Lab. 2016;62(7):1243–1248.
   PubMed Web of Science ®Google Scholar
• Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Am Stat. 1988;16(3):1141–1154.
   Google Scholar
• Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457–481.
   Web of Science ®Google Scholar
• Olsson R, Remberger M, Schaffer M, et al. Graft failure in the modern era of allogeneic hematopoietic SCT. Bone Marrow Transplant. 2013;48(4):537–543.
   PubMed Web of Science ®Google Scholar
• Olsson RF, Logan BR, Chaudhury S, et al. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia. 2015;29(8):1754–1762.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Vicent M, &, Perez MAD. Allogeneic hematopoietic stem-cell transplantation from haploidentical donor using ‘ex-vivo’ T-cell depletion in pediatric patients with hematological malignancies: state of the art review. Curr Opin Oncol. 2018; 30(6):396–401.
   PubMed Web of Science ®Google Scholar
• Booth C, Lawson S, Veys P. The current role of T cell depletion in paediatric stem cell transplantation. Br J Haematol. 2013;162(2):177–190.
   PubMed Web of Science ®Google Scholar
• Lang P, Teltschik H-M, Feuchtinger T, et al. Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia. Br J Haematol. 2014;165(5):688–698.
   PubMed Web of Science ®Google Scholar
• Lv M, Zhai SZ, Wang Y, et al. Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factors. Bone Marrow Transplant. 2019;54(8):1287–1294.
   PubMed Web of Science ®Google Scholar
• Focosi D, Zucca A, Scatena F. The role of anti-HLA antibodies in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17(11):1585–1588.
   PubMed Web of Science ®Google Scholar
• Baumeister SHC, Rambaldi B, Shapiro RM, et al. Key aspects of the immunobiology of haploidentical hematopoietic cell transplantation. Front Immunol. 2020;11:191.
   PubMed Web of Science ®Google Scholar
• Woodard P, Tong X, Richardson S, et al. Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients. J Pediatr Hematol Oncol. 2003;25(12):955–959.
   PubMed Web of Science ®Google Scholar
• Ferrà C, Sanz J, Díaz-Pérez MA, for the Grupo Español de Trasplante Hematopoyético (Geth) Spanish Society of Hematology, et al. Outcome of graft-failure after allogeneic stem cell transplantation: study of 89 patients. Leuk Lymphoma. 2015;56(3):656–662.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Lucarelli B, Merli P. Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation. Expert Opin Pharmacother. 2014;15(1):23–36.
   PubMed Web of Science ®Google Scholar
• Rubio MT, Kim YM, Sachs T, et al. Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-gamma. Blood. 2003;102(6):2300–2307.
   PubMed Web of Science ®Google Scholar
• Guardiola P, Kuentz M, Garban F, et al. French Society of Bone Marrow Transplantation. Second early allogeneic stem cell transplantations for graft failure in acute leukemia, chronic myeloid leukemia and aplastic anemia. Br J Haematol. 2000;111:292–302.
   PubMed Web of Science ®Google Scholar
• Rondon G, Saliba RM, Khouri I, et al. Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis. Biol Blood Marrow Transplant. 2008;14(8):859–866.
   PubMed Web of Science ®Google Scholar